Iovance Biotherapeutics, Inc. (IOVA)

NASDAQ: IOVA · Real-Time Price · USD

2.360

+0.140 (6.31%)

At close: Jan 16, 2026, 4:00 PM EST

2.379

+0.019 (0.81%)

After-hours: Jan 16, 2026, 7:59 PM EST

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Autologous Tumor Infiltrating Lymphocyte Cell Therapies	164.07M	Log In
Autologous Tumor Infiltrating Lymphocyte Cell Therapies Growth	13698.99%	Log In

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.